Human Vascular Smooth Muscle Function and Oxidative Stress Induced by NADPH Oxidase with the Clinical Implications.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
31 07 2021
Historique:
received: 06 07 2021
revised: 28 07 2021
accepted: 29 07 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 17 11 2021
Statut: epublish

Résumé

Among reactive oxygen species, superoxide mediates the critical vascular redox signaling, resulting in the regulation of the human cardiovascular system. The reduced form of nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase, NOX) is the source of superoxide and relates to the crucial intracellular pathology and physiology of vascular smooth muscle cells, including contraction, proliferation, apoptosis, and inflammatory response. Human vascular smooth muscle cells express NOX1, 2, 4, and 5 in physiological and pathological conditions, and those enzymes play roles in most cardiovascular disorders caused by hypertension, diabetes, inflammation, and arteriosclerosis. Various physiologically active substances, including angiotensin II, stimulate NOX via the cytosolic subunits' translocation toward the vascular smooth muscle cell membrane. As we have shown, some pathological stimuli such as high glucose augment the enzymatic activity mediated by the phosphatidylinositol 3-kinase-Akt pathway, resulting in the membrane translocation of cytosolic subunits of NOXs. This review highlights and details the roles of human vascular smooth muscle NOXs in the pathophysiology and clinical aspects. The regulation of the enzyme expressed in the vascular smooth muscle cells may lead to the prevention and treatment of human cardiovascular diseases.

Identifiants

pubmed: 34440716
pii: cells10081947
doi: 10.3390/cells10081947
pmc: PMC8393371
pii:
doi:

Substances chimiques

Isoenzymes 0
Superoxides 11062-77-4
NADPH Oxidases EC 1.6.3.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 21K08949 (H.K.); 20K09219 (S.K.); 20K10181 (K.T.)

Références

Sci Rep. 2020 Oct 20;10(1):17818
pubmed: 33082354
Am J Physiol. 1997 Aug;273(2 Pt 2):H718-24
pubmed: 9277488
Free Radic Biol Med. 2009 Nov 1;47(9):1239-53
pubmed: 19628035
Anesth Analg. 2012 Jul;115(1):54-61
pubmed: 22467893
J Clin Invest. 2016 Jan;126(1):50-67
pubmed: 26595812
Circ Res. 2019 Feb 15;124(4):564-574
pubmed: 30582458
Circ Res. 2001 Jul 6;89(1):47-54
pubmed: 11440977
J Biol Chem. 2003 Jun 20;278(25):22546-54
pubmed: 12692136
Diabetes. 2015 Jun;64(6):2207-19
pubmed: 25552596
Chest. 1995 May;107(5):1193-8
pubmed: 7750305
Circ Res. 2020 Sep 11;127(7):911-927
pubmed: 32564697
J Anesth. 2012 Feb;26(1):141-2
pubmed: 22089629
Oncotarget. 2016 Oct 11;7(41):66429-66443
pubmed: 27655718
Biochem Biophys Res Commun. 1999 Oct 5;263(3):681-4
pubmed: 10512739
J Am Coll Cardiol. 2008 Nov 25;52(22):1810-2
pubmed: 19022161
Hypertension. 2008 Sep;52(3):507-13
pubmed: 18678787
Trends Pharmacol Sci. 2003 Sep;24(9):471-8
pubmed: 12967772
Cardiovasc Res. 2005 Jan 1;65(1):16-27
pubmed: 15621030
J Am Coll Cardiol. 2008 Nov 25;52(22):1803-9
pubmed: 19022160
Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):333-9
pubmed: 16293794
Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):105-12
pubmed: 19834108
Heliyon. 2017 Aug 02;3(8):e00369
pubmed: 28808694
Circ Res. 2012 Apr 27;110(9):1217-25
pubmed: 22456182
Hematol Oncol Clin North Am. 1988 Jun;2(2):201-12
pubmed: 2839456
J Mol Cell Cardiol. 2020 Jan;138:256-268
pubmed: 31866376
J Am Coll Cardiol. 2008 Apr 8;51(14):1349-56
pubmed: 18387435
Arterioscler Thromb Vasc Biol. 2008 May;28(5):878-85
pubmed: 18309110
J Cell Mol Med. 2006 Jan-Mar;10(1):231-9
pubmed: 16563235
Cardiovasc Res. 2006 Jul 15;71(2):310-21
pubmed: 16581043
Oxid Med Cell Longev. 2018 Dec 23;2018:5835072
pubmed: 30671170
Prostaglandins Leukot Essent Fatty Acids. 2008 Apr-May;78(4-5):247-55
pubmed: 18420399
Circ Res. 2002 Jun 14;90(11):1205-13
pubmed: 12065324
Physiol Rev. 2007 Jan;87(1):245-313
pubmed: 17237347
J Biol Chem. 2001 Oct 5;276(40):37594-601
pubmed: 11483596
Free Radic Biol Med. 2018 Apr;118:44-58
pubmed: 29471108
Clin Sci (Lond). 2013 Aug;125(4):167-82
pubmed: 23634936
Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):981-7
pubmed: 12663375
J Am Heart Assoc. 2017 Feb 28;6(3):
pubmed: 28246076
Biochem J. 1984 Apr 1;219(1):1-14
pubmed: 6326753
Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):512-8
pubmed: 15618548
Int J Cardiol. 2016 Nov 1;222:901-907
pubmed: 27526356
J Neurotrauma. 2001 Oct;18(10):1039-48
pubmed: 11686491
Redox Biol. 2013 Aug 26;1:411-7
pubmed: 24191234
Circ Res. 2012 Aug 31;111(6):697-707
pubmed: 22798525
Free Radic Biol Med. 2015 Mar;80:111-20
pubmed: 25557278
Circulation. 2002 Apr 9;105(14):1656-62
pubmed: 11940543
Eur J Pharmacol. 2011 May 11;658(2-3):187-92
pubmed: 21371456
Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2290-5
pubmed: 15486306
J Am Heart Assoc. 2018 Jun 15;7(12):
pubmed: 29907654
Cardiovasc Res. 2018 Mar 15;114(4):529-539
pubmed: 29394331
Cardiovasc Res. 2006 Jul 15;71(2):216-25
pubmed: 16616906
J Hypertens. 2007 Mar;25(3):609-18
pubmed: 17278978
J Pharmacol Sci. 2020 Dec;144(4):197-203
pubmed: 33070838
J Pharmacol Exp Ther. 2006 Jul;318(1):312-8
pubmed: 16574781
BMC Pulm Med. 2018 Jul 9;18(1):111
pubmed: 29986678

Auteurs

Kazumi Takaishi (K)

Department of Dental Anesthesiology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15, Kuramoto, Tokushima 770-8504, Japan.

Hiroyuki Kinoshita (H)

Department of Anesthesiology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15, Kuramoto, Tokushima 770-8504, Japan.
Department of Anesthesiology and Intensive Care, School of Medicine, Hamamatsu University, 1-20-1, Handayama, Hamamatsu City 431-3192, Japan.

Shingo Kawashima (S)

Department of Anesthesiology and Intensive Care, School of Medicine, Hamamatsu University, 1-20-1, Handayama, Hamamatsu City 431-3192, Japan.

Shinji Kawahito (S)

Department of Dental Anesthesiology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15, Kuramoto, Tokushima 770-8504, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH